Pfizer S Bivalent Booster Is Not Linked To Increased Stroke Risk
Last week, a Centers for Disease Control and Prevention (CDC) vaccine monitoring database signaled a possible increased risk of ischemic strokes from Pfizer’s bivalent COVID-19 booster in adults 65 and older. Key Takeaways A CDC vaccine database signaled a safety concern for ischemic stroke in people ages 65 and older who received Pfizer’s COVID-19 bivalent booster.So far, the totality of vaccine data suggests that the signal doesn’t represent an actual clinical risk....